Your browser doesn't support javascript.
loading
A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction.
Coassin, Stefan; Erhart, Gertraud; Weissensteiner, Hansi; Eca Guimarães de Araújo, Mariana; Lamina, Claudia; Schönherr, Sebastian; Forer, Lukas; Haun, Margot; Losso, Jamie Lee; Köttgen, Anna; Schmidt, Konrad; Utermann, Gerd; Peters, Annette; Gieger, Christian; Strauch, Konstantin; Finkenstedt, Armin; Bale, Reto; Zoller, Heinz; Paulweber, Bernhard; Eckardt, Kai-Uwe; Hüttenhofer, Alexander; Huber, Lukas A; Kronenberg, Florian.
Afiliação
  • Coassin S; Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Schoepfstrasse 41, 6020 Innsbruck, Austria.
  • Erhart G; Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Schoepfstrasse 41, 6020 Innsbruck, Austria.
  • Weissensteiner H; Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Schoepfstrasse 41, 6020 Innsbruck, Austria.
  • Eca Guimarães de Araújo M; Division of Cell Biology, Biocenter, Medical University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria.
  • Lamina C; Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Schoepfstrasse 41, 6020 Innsbruck, Austria.
  • Schönherr S; Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Schoepfstrasse 41, 6020 Innsbruck, Austria.
  • Forer L; Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Schoepfstrasse 41, 6020 Innsbruck, Austria.
  • Haun M; Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Schoepfstrasse 41, 6020 Innsbruck, Austria.
  • Losso JL; Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Schoepfstrasse 41, 6020 Innsbruck, Austria.
  • Köttgen A; Division of Genetic Epidemiology, Division of Genetic Epidemiology - Faculty of Medicine and Medical Center - University of Freiburg, Hugstetter Strasse 49, 79106 Freiburg, Germany.
  • Schmidt K; Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Schoepfstrasse 41, 6020 Innsbruck, Austria.
  • Utermann G; Division of Human Genetics, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Peter-Mayr-Strasse 1, 6020 Innsbruck, Austria.
  • Peters A; German Center for Diabetes Research, Ingolstaedter Landstrasse 1, 85764 Neuherberg, Germany.
  • Gieger C; Institute of Epidemiology II, Helmholtz Zentrum München - German Research Center for Environmental Health, Ingolstaedter Landstrasse 1, 85764 Neuherberg, Germany.
  • Strauch K; Munich Heart Alliance, German Center for Cardiovascular Disease Research, Ingolstaedter Landstrasse 1, 85764 Neuherberg, Germany.
  • Finkenstedt A; Institute of Epidemiology II, Helmholtz Zentrum München - German Research Center for Environmental Health, Ingolstaedter Landstrasse 1, 85764 Neuherberg, Germany.
  • Bale R; Research Unit of Molecular Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Ingolstaedter Landstrasse 1, 85764 Neuherberg, Germany.
  • Zoller H; Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Ingolstaedter Landstrasse 1, 85764 Neuherberg, Germany.
  • Paulweber B; Institute of Medical Informatics, Biometry and Epidemiology, Chair of Genetic Epidemiology, Ludwig-Maximilians-Universität, Marchioninistrasse 15, 81377 Munich, Germany.
  • Eckardt KU; Internal Medicine I, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
  • Hüttenhofer A; Section of Interventional Oncology - Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
  • Huber LA; Internal Medicine I, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
  • Kronenberg F; First Department of Internal Medicine, Paracelsus Private Medical University, Müllner Hauptstrasse 48, 5020 Salzburg, Austria.
Eur Heart J ; 38(23): 1823-1831, 2017 Jun 14.
Article em En | MEDLINE | ID: mdl-28444229
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Lipoproteína(a) / Kringles Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Heart J Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Lipoproteína(a) / Kringles Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Heart J Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Áustria